Menorrhagia in Women After the Administration of Novel Oral Anticoagulants, Like Rivaroxaban: A Case Report

Background: The Novel Oral Anticoagulants (NOACs), despite numerous benefits, such as the ease of use and less drug involvement, provide extensive adverse effects. One of the most significant, but rare side effects of them in women is severe and dangerous bleeding Case presentation: In this study,...

Full description

Bibliographic Details
Main Authors: Abbas‎ Ghaysouri, Mahtab Bonyadi, Elham Shafiei
Format: Article
Language:English
Published: Shaheed Beheshti University of Medical Sciences 2020-09-01
Series:International Journal of Medical Toxicology and Forensic Medicine
Subjects:
Online Access:https://doi.org/10.32598/ijmtfm.v10i3.29640
_version_ 1818530835955974144
author Abbas‎ Ghaysouri
Mahtab Bonyadi
Elham Shafiei
author_facet Abbas‎ Ghaysouri
Mahtab Bonyadi
Elham Shafiei
author_sort Abbas‎ Ghaysouri
collection DOAJ
description Background: The Novel Oral Anticoagulants (NOACs), despite numerous benefits, such as the ease of use and less drug involvement, provide extensive adverse effects. One of the most significant, but rare side effects of them in women is severe and dangerous bleeding Case presentation: In this study, we reported a case of severe vaginal bleeding (manometric hemorrhage) in a woman receiving rivaroxaban to prevent pulmonary thrombosis. Conclusion: The oral anticoagulant rivaroxaban could present a rare adverse effect on women.
first_indexed 2024-12-11T17:24:44Z
format Article
id doaj.art-b92b7e8010624069a1b524623c67409b
institution Directory Open Access Journal
issn 2251-8762
language English
last_indexed 2024-12-11T17:24:44Z
publishDate 2020-09-01
publisher Shaheed Beheshti University of Medical Sciences
record_format Article
series International Journal of Medical Toxicology and Forensic Medicine
spelling doaj.art-b92b7e8010624069a1b524623c67409b2022-12-22T00:57:00ZengShaheed Beheshti University of Medical SciencesInternational Journal of Medical Toxicology and Forensic Medicine2251-87622020-09-0110310.32598/ijmtfm.v10i3.29640Menorrhagia in Women After the Administration of Novel Oral Anticoagulants, Like Rivaroxaban: A Case ReportAbbas‎ GhaysouriMahtab BonyadiElham ShafieiBackground: The Novel Oral Anticoagulants (NOACs), despite numerous benefits, such as the ease of use and less drug involvement, provide extensive adverse effects. One of the most significant, but rare side effects of them in women is severe and dangerous bleeding Case presentation: In this study, we reported a case of severe vaginal bleeding (manometric hemorrhage) in a woman receiving rivaroxaban to prevent pulmonary thrombosis. Conclusion: The oral anticoagulant rivaroxaban could present a rare adverse effect on women.https://doi.org/10.32598/ijmtfm.v10i3.29640vascular thrombosisrivaroxabananticoagulant
spellingShingle Abbas‎ Ghaysouri
Mahtab Bonyadi
Elham Shafiei
Menorrhagia in Women After the Administration of Novel Oral Anticoagulants, Like Rivaroxaban: A Case Report
International Journal of Medical Toxicology and Forensic Medicine
vascular thrombosis
rivaroxaban
anticoagulant
title Menorrhagia in Women After the Administration of Novel Oral Anticoagulants, Like Rivaroxaban: A Case Report
title_full Menorrhagia in Women After the Administration of Novel Oral Anticoagulants, Like Rivaroxaban: A Case Report
title_fullStr Menorrhagia in Women After the Administration of Novel Oral Anticoagulants, Like Rivaroxaban: A Case Report
title_full_unstemmed Menorrhagia in Women After the Administration of Novel Oral Anticoagulants, Like Rivaroxaban: A Case Report
title_short Menorrhagia in Women After the Administration of Novel Oral Anticoagulants, Like Rivaroxaban: A Case Report
title_sort menorrhagia in women after the administration of novel oral anticoagulants like rivaroxaban a case report
topic vascular thrombosis
rivaroxaban
anticoagulant
url https://doi.org/10.32598/ijmtfm.v10i3.29640
work_keys_str_mv AT abbasghaysouri menorrhagiainwomenaftertheadministrationofnoveloralanticoagulantslikerivaroxabanacasereport
AT mahtabbonyadi menorrhagiainwomenaftertheadministrationofnoveloralanticoagulantslikerivaroxabanacasereport
AT elhamshafiei menorrhagiainwomenaftertheadministrationofnoveloralanticoagulantslikerivaroxabanacasereport